High Expression of PHGDH Predicts Poor Prognosis in Non-Small Cell Lung Cancer.
In conclusion, this study suggested the clinical implication of PHGDH in NSCLC. PHGDH may be a promising therapeutic target in NSCLC.
PMID: 27916294 [PubMed - in process]
Source: Translational Oncology - Category: Cancer & Oncology Authors: Zhu J, Ma J, Wang X, Ma T, Zhang S, Wang W, Zhou X, Shi J Tags: Transl Oncol Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cervical Cancer | Colon Cancer | Colorectal Cancer | Genetics | Lung Cancer | Melanoma | Non-Small Cell Lung Cancer | Skin Cancer | Study